1. Home
  2. ABVX vs EAT Comparison

ABVX vs EAT Comparison

Compare ABVX & EAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABVX
  • EAT
  • Stock Information
  • Founded
  • ABVX 2013
  • EAT 1975
  • Country
  • ABVX France
  • EAT United States
  • Employees
  • ABVX N/A
  • EAT N/A
  • Industry
  • ABVX
  • EAT Restaurants
  • Sector
  • ABVX
  • EAT Consumer Discretionary
  • Exchange
  • ABVX Nasdaq
  • EAT Nasdaq
  • Market Cap
  • ABVX 6.7B
  • EAT 7.0B
  • IPO Year
  • ABVX N/A
  • EAT N/A
  • Fundamental
  • Price
  • ABVX $104.29
  • EAT $108.09
  • Analyst Decision
  • ABVX Strong Buy
  • EAT Buy
  • Analyst Count
  • ABVX 10
  • EAT 15
  • Target Price
  • ABVX $103.80
  • EAT $165.93
  • AVG Volume (30 Days)
  • ABVX 1.1M
  • EAT 1.5M
  • Earning Date
  • ABVX 08-11-2025
  • EAT 10-29-2025
  • Dividend Yield
  • ABVX N/A
  • EAT N/A
  • EPS Growth
  • ABVX N/A
  • EAT 136.76
  • EPS
  • ABVX N/A
  • EAT 9.64
  • Revenue
  • ABVX $7,073,400.00
  • EAT $5,594,400,000.00
  • Revenue This Year
  • ABVX $4.44
  • EAT $7.11
  • Revenue Next Year
  • ABVX N/A
  • EAT $5.12
  • P/E Ratio
  • ABVX N/A
  • EAT $11.92
  • Revenue Growth
  • ABVX N/A
  • EAT 23.18
  • 52 Week Low
  • ABVX $4.77
  • EAT $95.60
  • 52 Week High
  • ABVX $98.94
  • EAT $192.22
  • Technical
  • Relative Strength Index (RSI)
  • ABVX 74.51
  • EAT 26.37
  • Support Level
  • ABVX $90.85
  • EAT $124.00
  • Resistance Level
  • ABVX $94.26
  • EAT $129.00
  • Average True Range (ATR)
  • ABVX 3.46
  • EAT 5.10
  • MACD
  • ABVX 0.17
  • EAT -0.76
  • Stochastic Oscillator
  • ABVX 96.24
  • EAT 5.21

About ABVX Abivax SA American

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD.

About EAT Brinker International Inc.

Brinker International Inc operates casual dining restaurants under the brand's Chili Grill and Bar (Chili's) and Maggiano's Little Italy (Maggiano's). Chili's falls in the Bar and Grill category of casual dining. Its menu features Fresh Mex and Fresh Tex favorites including signature items such as slow-smoked baby back ribs, craft burgers, fajitas, and bottomless chips and salsa paired with tableside guacamole. Maggiano's is an Italian restaurant brand with a full lunch and dinner menu offering chef-prepared, such as appetizers, chicken, seafood, veal and prime steaks, and desserts. The company generates maximum revenue from Chili's segment.

Share on Social Networks: